The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis
Open accessAbstract
OBJECTIVE: To evaluate whether including a test for faecal calprotectin, a sensitive marker of intestinal inflammation, in the investigation of suspected inflammatory bowel disease reduces the number of unnecessary endoscopic procedures. DESIGN: Meta-analysis of diagnostic accuracy studies. DATA SOURCES: Studies published in Medline and Embase up to October 2009. Interventions reviewed Measurement of faecal calprotectin level (index test) compared with endoscopy and histopathology of segmental biopsy samples (reference standard). Inclusion criteria Studies that had collected data prospectively in patients with suspected inflammatory bowel disease and allowed for construction of a two by two table. For each study, sensitivity and specificity of faecal calprotectin were analysed as bivariate data to account for a possible negative correlation within studies. RESULTS: 13 studies were included: six in adults (n=670), seven in children and teenagers (n=371). Inflammatory bowel disease was confirmed by endoscopy in 32% (n=215) of the adults and 61% (n=226) of the children and teenagers. In the studies of adults, the pooled sensitivity and pooled specificity of calprotectin was 0.93 (95% confidence interval 0.85 to 0.97) and 0.96 (0.79 to 0.99) and in the studies of children and teenagers was 0.92 (0.84 to 0.96) and 0.76 (0.62 to 0.86). The lower specificity in the studies of children and teenagers was significantly different from that in the studies of adults (P=0.048). Screening by measuring faecal calprotectin levels would result in a 67% reduction in the number of adults requiring endoscopy. Three of 33 adults who undergo endoscopy will not have inflammatory bowel disease but may have a different condition for which endoscopy is inevitable. The downside of this screening strategy is delayed diagnosis in 6% of adults because of a false negative test result. In the population of children and teenagers, 65 instead of 100 would undergo endoscopy. Nine of them will not have inflammatory bowel disease, and diagnosis will be delayed in 8% of the affected children. CONCLUSION: Testing for faecal calprotectin is a useful screening tool for identifying patients who are most likely to need endoscopy for suspected inflammatory bowel disease. The discriminative power to safely exclude inflammatory bowel disease was significantly better in studies of adults than in studies of children.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Whiting, P., Rutjes, A. W., Reitsma, J. B., Bossuyt, P. M., & Kleijnen, J. (2003) · BMC Medical Research Methodology · doi:10.1186/1471-2288-3-25 · Cited by 3,592
What is ‘quality of evidence’ and why is it important to clinicians?
Guyatt, G. H., Oxman, A. D., Kunz, R., Vist, G. E., Falck-Ytter, Y., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39490.551019.be · Cited by 3,250
Grading quality of evidence and strength of recommendations for diagnostic tests and strategies
Schünemann, H. J., Oxman, A. D., Brozek, J., Glasziou, P., Jaeschke, R., Vist, G. E., Williams, J. W., Kunz, R., Craig, J., Montori, V. M., et al. (2008) · BMJ · doi:10.1136/bmj.39500.677199.ae · Cited by 1,782
Van Assche, G., Dignass, A., Panes, J., Beaugerie, L., Karagiannis, J., Allez, M., Ochsenkühn, T., Orchard, T., Rogler, G., Louis, E., et al. (2010) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2009.12.003 · Cited by 1,453
ESPGHAN and ESPEN Guidelines Paediatric Parenteral Nutrition ‐ Annex: List of Products
(2005) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/01.mpg.0000181841.07090.f4 · Cited by 1,231
Laboratory markers in IBD: useful, magic, or unnecessary toys?
Vermeire, S., Van Assche, G., & Rutgeerts, P. (2006) · Gut · doi:10.1136/gut.2005.069476 · Cited by 952
Guidelines on the irritable bowel syndrome: mechanisms and practical management
Spiller, R., Aziz, Q., Creed, F., Emmanuel, A., Houghton, L., Hungin, P., Jones, R., Kumar, D., Rubin, G., Trudgill, N., et al. (2007) · Gut · doi:10.1136/gut.2007.119446 · Cited by 818
Tibble, J. A., Sigthorsson, G., Bridger, S., Fagerhol, M. K., & Bjarnason, I. (2000) · Gastroenterology · doi:10.1053/gast.2000.8523 · Cited by 759
A unification of models for meta-analysis of diagnostic accuracy studies
Harbord, R. M., Deeks, J. J., Egger, M., Whiting, P., & Sterne, J. A. C. (2007) · Biostatistics · doi:10.1093/biostatistics/kxl004 · Cited by 751
IBD Working Group of the European Society for Paediatric Gastroenterology, H. A. N. (. (2005) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/01.mpg.0000163736.30261.82 · Cited by 702
Assessment of the Neutrophil Dominating Protein Calprotectin in Feces: A Methodologic Study
RØseth, A. G., Fagerhol, M. K., Aadland, E., & Schjønsby, H. (1992) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529209011186 · Cited by 669
Langhorst, J., Elsenbruch, S., Koelzer, J., Rueffer, A., Michalsen, A., & Dobos, G. J. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01556.x · Cited by 591
Costa, F., Mumolo, M. G., Ceccarelli, L., Bellini, M., Romano, M. R., Sterpi, C., Ricchiuti, A., Marchi, S., & Bottai, M. (2005) · Gut · doi:10.1136/gut.2004.043406 · Cited by 550
Stange, E. F., Travis, S. P. L., Vermeire, S., Beglinger, C., Kupcinkas, L., Geboes, K., Barakauskiene, A., Villanacci, V, Von Herbay, A., Warren, B. F., et al. (2006) · Gut · doi:10.1136/gut.2005.081950a · Cited by 510
A simple method for assessing intestinal inflammation in Crohn's disease
Tibble, J., Teahon, K., Thjodleifsson, B., Roseth, A., Sigthorsson, G., Bridger, S., Foster, R., Sherwood, R., Fagerhol, M., & Bjarnason, I. (2000) · Gut · doi:10.1136/gut.47.4.506 · Cited by 492
Sipponen, T., Savilahti, E., Kolho, K.-L., Nuutinen, H., Turunen, U., & Färkkilä, M. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20312 · Cited by 480
Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease
Konikoff, M. R., & Denson, L. A. (2006) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200606000-00013 · Cited by 453
Tibble, J. A., Sigthorsson, G., Foster, R., Forgacs, I., & Bjarnason, I. (2002) · Gastroenterology · doi:10.1053/gast.2002.34755 · Cited by 441
A. G. Røseth, P. N. S. (1999) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365529950172835 · Cited by 422
Jones, J., Loftus, E. V., Panaccione, R., Chen, L., Peterson, S., Mcconnell, J., Baudhuin, L., Hanson, K., Feagan, B. G., Harmsen, S. W., et al. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.06.010 · Cited by 414
Benchimol, E. I., Guttmann, A., Griffiths, A. M., Rabeneck, L., Mack, D. R., Brill, H., Howard, J., Guan, J., & To, T. (2009) · Gut · doi:10.1136/gut.2009.188383 · Cited by 414
Diagnostic Precision of Fecal Calprotectin for Inflammatory Bowel Disease and Colorectal Malignancy
von Roon, A. C., Karamountzos, L., Purkayastha, S., Reese, G. E., Darzi, A. W., Teare, J. P., Paraskeva, P., & Tekkis, P. P. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01126.x · Cited by 401
Carter, T. (2003) · Scandinavian Journal of Work, Environment & Health · doi:10.5271/sjweh.1021 · Cited by 343
No role for quality scores in systematic reviews of diagnostic accuracy studies
Whiting, P., Harbord, R., & Kleijnen, J. (2005) · BMC Medical Research Methodology · doi:10.1186/1471-2288-5-19 · Cited by 337
Schoepfer, A. M., Beglinger, C., Straumann, A., Trummler, M., Renzulli, P., & Seibold, F. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20986 · Cited by 326
SIPPONEN, T., KÄRKKÄINEN, P., SAVILAHTI, E., KOLHO, K. ‐., NUUTINEN, H., TURUNEN, U., & FÄRKKILÄ, M. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03835.x · Cited by 324
Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse
Gisbert, J. P., Bermejo, F., Pérez-Calle, J.-L., Taxonera, C., Vera, I., McNicholl, A. G., Algaba, A., López, P., López-Palacios, N., Calvo, M., et al. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20933 · Cited by 315
High prevalence of NSAID enteropathy as shown by a simple faecal test
Tibble, J. A., Sigthorsson, G., Foster, R., Scott, D., Fagerhol, M. K., Roseth, A., & Bjarnason, I. (1999) · Gut · doi:10.1136/gut.45.3.362 · Cited by 307
Role of faecal calprotectin as non-invasive marker of intestinal inflammation
Costa, F., Mumolo, M. G., Bellini, M., Romano, M. R., Ceccarelli, L., Arpe, P., Sterpi, C., Marchi, S., & Maltinti, G. (2003) · Digestive and Liver Disease · doi:10.1016/s1590-8658(03)00381-5 · Cited by 289
Schoepfer, A. M., Trummler, M., Seeholzer, P., Seibold-Schmid, B., & Seibold, F. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20275 · Cited by 287
The Evidence Base of Clinical Diagnosis: Theory and methods of diagnostic research
(2008) · Wiley eBooks · doi:10.1002/9781444300574 · Cited by 276
CASELLAS, F., BORRUEL, N., TORREJÓN, A., VARELA, E., ANTOLIN, M., GUARNER, F., & MALAGELADA, J. ‐. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03288.x · Cited by 259
Gisbert, J. P., & McNicholl, A. G. (2009) · Digestive and Liver Disease · doi:10.1016/j.dld.2008.05.008 · Cited by 238
Bunn, S. K., Bisset, W. M., Main, M. J. C., Gray, E. S., Olson, S., & Golden, B. E. (2001) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1002/j.1536-4801.2001.tb07395.x · Cited by 237
Sipponen, T., Savilahti, E., Kärkkäinen, P., Kolho, K.-L., Nuutinen, H., Turunen, U., & Färkkilä, M. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20490 · Cited by 236
Carroccio, A., Iacono, G., Cottone, M., Di Prima, L., Cartabellotta, F., Cavataio, F., Scalici, C., Montalto, G., Di Fede, G., Rini, G., et al. (2003) · Clinical Chemistry · doi:10.1373/49.6.861 · Cited by 221
Foell, D., Wittkowski, H., & Roth, J. (2009) · Gut · doi:10.1136/gut.2008.170019 · Cited by 217
Calprotectin and lactoferrin in the assessment of intestinal inflammation and organic disease
D’Incà, R., Dal Pont, E., Di Leo, V., Ferronato, A., Fries, W., Vettorato, M. G., Martines, D., & Sturniolo, G. C. (2007) · International Journal of Colorectal Disease · doi:10.1007/s00384-006-0159-9 · Cited by 215
Kaiser, T., Langhorst, J., Wittkowski, H., Becker, K., Friedrich, A. W., Rueffer, A., Dobos, G. J., Roth, J., & Foell, D. (2007) · Gut · doi:10.1136/gut.2006.113431 · Cited by 212
Can Calprotectin Predict Relapse Risk in Inflammatory Bowel Disease?
D'Incà, R., Dal Pont, E., Di Leo, V., Benazzato, L., Martinato, M., Lamboglia, F., Oliva, L., & Carlo Sturniolo, G. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01870.x · Cited by 211
Crohn's disease: monitoring disease activity
Sostegni, R., Daperno, M., Scaglione, N., Lavagna, A., Rocca, R., & Pera, A. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.17.s2.17.x · Cited by 208
Faecal calprotectin: a marker of inflammation throughout the intestinal tract
Aadland, E., & Fagerhol, M. K. (2002) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200208000-00002 · Cited by 207
Fecal Calprotectin as a Measure of Disease Activity in Childhood Inflammatory Bowel Disease
Bunn, S. K., Bisset, W. M., Main, M. J. C., & Golden, B. E. (2001) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1002/j.1536-4801.2001.tb07239.x · Cited by 205
Olafsdottir, E. J., Aksnes, L., FLUGE, G., & Berstad, A. (2002) · Acta Paediatrica · doi:10.1080/080352502753457932 · Cited by 200
Patient preferences for CT colonography, conventional colonoscopy, and bowel preparation
Ristvedt, S. (2003) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(02)06024-0 · Cited by 199
Bruzzese, E., Raia, V., Gaudiello, G., Polito, G., Buccigrossi, V., Formicola, V., & Guarino, A. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.02174.x · Cited by 195
Faecal calprotectin: a marker of inflammation throughout the intestinal tract
Summerton, C. B., Longlands, M. G., Wiener, K., & Shreeve, D. R. (2002) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200208000-00005 · Cited by 187
Berni Canani, R., Terrin, G., Rapacciuolo, L., Miele, E., Siani, M. C., Puzone, C., Cosenza, L., Staiano, A., & Troncone, R. (2008) · Digestive and Liver Disease · doi:10.1016/j.dld.2008.01.017 · Cited by 175
Limburg, P. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)01987-0 · Cited by 171
Fecal Calprotectin Predicts the Clinical Course of Acute Severe Ulcerative Colitis
Ho, G. T., Lee, H. M., Brydon, G., Ting, T., Hare, N., Drummond, H., Shand, A. G., Bartolo, D. C., Wilson, R. G., Dunlop, M. G., et al. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2008.119 · Cited by 171
Non-invasive investigation of inflammatory bowel disease
Tibble, J. (2001) · World Journal of Gastroenterology · doi:10.3748/wjg.v7.i4.460 · Cited by 167
Sidler, M. A., Leach, S. T., & Day, A. S. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20336 · Cited by 154
Diagnostic value of faecal calprotectin in paediatric gastroenterology clinical practice
Canani, R. B., Rapacciuolo, L., Romano, M. T., de Horatio, L. T., Terrin, G., Manguso, F., Cirillo, P. L., Paparo, F., & Troncone, R. (2004) · Digestive and Liver Disease · doi:10.1016/j.dld.2004.02.009 · Cited by 153
Wagner, M. S., Peterson, C. G. B., Ridefelt, P., Sangfelt, P., & Carlson, M. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.5584 · Cited by 149
Langhorst, J., Elsenbruch, S., Mueller, T., Rueffer, A., Spahn, G., Michalsen, A., & Dobos, G. J. (2005) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000187980.08686.18 · Cited by 147
Review article: biological activity markers in inflammatory bowel disease
Desai, D., Faubion, W. A., & Sandborn, W. J. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03184.x · Cited by 146
Fecal calprotectin is useful in predicting disease relapse in pediatric inflammatory bowel disease
Walkiewicz, D., Werlin, S. L., Fish, D. L., Scanlon, M. C., Hanaway, P. J., & Kugathasan, S. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20376 · Cited by 135
Kolho, K., Raivio, T., Lindahl, H. G., & Savilahti, E. (2006) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520500419623 · Cited by 133
Perminow, G., Brackmann, S. A., Lyckander, L. G., Franke, A., Borthne, A., Rydning, A., Aamodt, G., Schreiber, S., Vatn, M. H., & The IBSEN-II Group (2009) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520802647434 · Cited by 132
Canani, R. B., de Horatio, L. T., Terrin, G., Romano, M. T., Miele, E., Staiano, A., Rapacciuolo, L., Polito, G., Bisesti, V., Manguso, F., et al. (2005) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/01.mpg.0000187818.76954.9a · Cited by 129
Fagerberg, U. L., Lööf, L., Lindholm, J., Hansson, L., & Finkel, Y. (2007) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e31810e75a9 · Cited by 125
Gisbert, J. P., McNicholl, A. G., & Gomollón, F. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20920 · Cited by 122
Enzymes in feces: Useful markers of chronic inflammatory bowel disease
Angriman, I., Scarpa, M., Renata D'Incà, Basso, D., Ruffolo, C., Polese, L., Sturniolo, G. C., D'Amico, D. F., & Plebani, M. (2007) · Clinica Chimica Acta · doi:10.1016/j.cca.2007.02.025 · Cited by 119
Clinical value of fecal calprotectin in determining disease activity of ulcerative colitis
Xiang, J.-Y., Ouyang, Q., Li, G., & Xiao, N. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.53 · Cited by 119
Kallel, L., Ayadi, I., Matri, S., Fekih, M., Mahmoud, N. B., Feki, M., Karoui, S., Zouari, B., Boubaker, J., Kaabachi, N., et al. (2010) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e32832bab49 · Cited by 118
Fecal leukocyte proteins in inflammatory bowel disease and irritable bowel syndrome.
Silberer, H., Küppers, B., Mickisch, O., Baniewicz, W., Drescher, M., Traber, L., Kempf, A., & Schmidt‐Gayk, H. (2005) · PubMed · Cited by 114
Review of Fecal Biomarkers in Inflammatory Bowel Disease
Sutherland, A. D., Gearry, R. B., & Frizelle, F. (2008) · Diseases of the Colon & Rectum · doi:10.1007/s10350-008-9310-8 · Cited by 113
Prospective Multicenter Study Evaluating Fecal Calprotectin in Adult Acute Bacterial Diarrhea
Shastri, Y. M., Bergis, D., Povse, N., Schäfer, V., Shastri, S., Weindel, M., Ackermann, H., & Stein, J. M. (2008) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.06.034 · Cited by 111
Age-Dependent Variations in Fecal Calprotectin Concentrations in Children
Rugtveit, J., & Fagerhol, M. K. (2002) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-200203000-00022 · Cited by 111
Araghizadeh, F. Y., Timmcke, A. E., Opelka, F. G., Hicks, T. C., & Beck, D. E. (2001) · Diseases of the Colon & Rectum · doi:10.1007/bf02234572 · Cited by 101
Hydrolyzed Versus Nonhydrolyzed Protein Diet in Short Bowel Syndrome in Children
Książyk, J., Piena, M., Kierkuś, J., & Łyszkowska, M. (2002) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1002/j.1536-4801.2002.tb07916.x · Cited by 99
Dolwani, S., Metzner, M., Wassell, J., Yong, A., & Hawthorne, A. B. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.02128.x · Cited by 99
Schröder, O., Naumann, M., Shastri, Y., Povse, N., & Stein, J. M. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03457.x · Cited by 98
Fecal Lactoferrin and Calprotectin After Ileocolonic Resection for Crohn's Disease
Scarpa, M., Renata D'Incà, Basso, D., Ruffolo, C., Polese, L., Bertin, E., Luise, A., Frego, M., Plebani, M., Sturniolo, G. C., et al. (2007) · Diseases of the Colon & Rectum · doi:10.1007/s10350-007-0225-6 · Cited by 97
Inflammatory bowel diseases: A disease (s) of modern times? Is incidence still increasing?
Gismera, C. S., & Aladrén, B. S. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.5491 · Cited by 96
Accuracy of Four Fecal Assays in the Diagnosis of Colitis
Schoepfer, A. M., Trummler, M., Seeholzer, P., Criblez, D., & Seibold, F. (2007) · Diseases of the Colon & Rectum · doi:10.1007/s10350-007-0303-9 · Cited by 93
Poullis, A. P., Foster, F., & Mendall, M. A. (2003) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200305000-00021 · Cited by 84
Damms-Machado, A., & Bischoff, S. C. (2008) · International Journal of Colorectal Disease · doi:10.1007/s00384-008-0506-0 · Cited by 83
Otten, C. M. T., Kok, L., Witteman, B. J. M., Baumgarten, R., Kampman, E., Moons, K. G. M., & de Wit, N. J. (2008) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2008.246 · Cited by 83
Lundberg, J. O., Hellström, P. M., Fagerhol, M. K., Weitzberg, E., & Røseth, A. G. (2005) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep0094 · Cited by 82
Fecal Calprotectin and Lactoferrin as Noninvasive Markers of Pediatric Inflammatory Bowel Disease
Joishy, M., Davies, I. H., Ahmed, M., Wassell, J., Davies, K., Sayers, A. E., & Jenkins, H. R. (2009) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e31816533d3 · Cited by 81
When are summary ROC curves appropriate for diagnostic meta‐analyses?
Chappell, F. M., RAAB, G. M., & Wardlaw, J. M. (2009) · Statistics in Medicine · doi:10.1002/sim.3631 · Cited by 81
Ashorn, S., Honkanen, T., Kolho, K., Ashorn, M. H., Välineva, T., Wei, B., Braun, J. G., Rantala, I. S., Luukkaala, T. H., & Iltanen, S. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20535 · Cited by 78
Diagnostic yield of colonoscopy based on symptoms
Lasson, A., Kilander, A. F., & Stotzer, P. (2008) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520701679116 · Cited by 77
Diamanti, A., Colistro, F., Basso, M. S., Papadatou, B., Francalanci, P., Bracci, F., Muraca, M., Knafelz, D., Angelis, P. D., & Castro, M. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20472 · Cited by 74
Is clinical remission the optimum therapeutic goal in the treatment of Crohn's disease?
Arnott, I. D., Watts, D., & Ghosh, S. K. (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2002.01242.x · Cited by 71
Faecal calprotectin in children with chronic gastrointestinal symptoms
Bremner, A., Roked, S., Robinson, R., Phillips, I., & Beattie, M. (2005) · Acta Paediatrica · doi:10.1111/j.1651-2227.2005.tb01870.x · Cited by 68
Fecal Calprotectin in Healthy Term and Preterm Infants
Nissen, A. C., van Gils, C. E., Menheere, P. P. C. A., den Neucker, A. M. V., van der Hoeven, M. A. H. B. M., & Forget, P. (2003) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-200401000-00025 · Cited by 58
Rectal nitric oxide and fecal calprotectin in inflammatory bowel disease
Reinders, C. I., Jonkers, D. M. A. E., Jansson, E. Å., Stockbrügger, R. W., Stobberingh, E. E., Hellström, P. M., & Lundberg, J. O. (2007) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520701320505 · Cited by 39
What predicts mucosal inflammation in Crohnʼs disease patients?
Minderhoud, I. M., Samsom, M., & Oldenburg, B. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20233 · Cited by 38
Otten, C. M. T., Kok, L., Witteman, B. J. M., et al. (2008) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2008.361 · Cited by 28
Fecal Calprotectin as a Predictor of Abnormal Colonic Histology
Shitrit, A. B., Braverman, D. Z., Stankiewics, H., Shitrit, D., Peled, N., & Paz, K. (2007) · Diseases of the Colon & Rectum · doi:10.1007/s10350-007-9038-x · Cited by 21
Advances in epidemiology and diagnosis of inflammatory bowel diseases
Ali, S., & Tamboli, C. (2008) · Current Gastroenterology Reports · doi:10.1007/s11894-008-0105-9 · Cited by 17
Hanauer, S. B., Present, D. H., & Rubin, D. T. (2009) · PubMed · Cited by 11
Shastri, Y., Povse, N., & Stein, J. M. (2009) · PubMed · Cited by 10
The S100A8 and S100A9 Proteins are Attractive Targets to Modulate Inflammation
Kerkhoff, C. (2007) · Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry · doi:10.2174/187152307781368247 · Cited by 1
Cited by
Torres, J., Mehandru, S., Colombel, J.-F., & Peyrin-Biroulet, L. (2017) · The Lancet · doi:10.1016/s0140-6736(16)31711-1 · Cited by 2,682
Kobayashi, T., Siegmund, B., Le Berre, C., Wei, S. C., Ferrante, M., Shen, B., Bernstein, C. N., Danese, S., Peyrin-Biroulet, L., & Hibi, T. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0205-x · Cited by 1,649
Roda, G., Chien Ng, S., Kotze, P. G., Argollo, M., Panaccione, R., Spinelli, A., Kaser, A., Peyrin-Biroulet, L., & Danese, S. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0156-2 · Cited by 1,023
Pennazio, M., Spada, C., Eliakim, R., Keuchel, M., May, A., Mulder, C., Rondonotti, E., Adler, S., Albert, J., Baltes, P., et al. (2015) · Endoscopy · doi:10.1055/s-0034-1391855 · Cited by 894
ACG Clinical Guideline: Management of Irritable Bowel Syndrome
Lacy, B. E., Pimentel, M., Brenner, D. M., Chey, W. D., Keefer, L. A., Long, M. D., & Moshiree, B. (2021) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001036 · Cited by 893
Metadata
- Authors
- van Rheenen, P. F., Van de Vijver, E., & Fidler, V.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2010-07-15
- Volume
- 341
- Issue
- jul15 1
- Pages
- c3369-c3369
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W2077129981
- Cited by
- 714
- References
- 96
- FWCI
- 18.27
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.